Tumor marker response to SARS-CoV-2 infection among patients with cancer암 환자의 SARS-CoV-2 감염에 대한 종양 표지자 반응Article Published on 2022-07-012022-09-11 Journal: Cancer Medicine [Category] [DOI] 10.1002/cam4.4646 PMC 바로가기 [Article Type] Article
Predictive factors for the presence and long-term persistence of SARS-CoV-2 antibodies in healthcare and university workers의료 및 대학 근로자에서 SARS-CoV-2 항체의 존재 및 장기간 지속성에 대한 예측 요인Article Published on 2022-06-132022-09-12 Journal: Scientific Reports [Category] [DOI] 10.1038/s41598-022-13450-4 PMC 바로가기 [Article Type] Article
Immune Response after 2 Doses of BNT162b2 mRNA COVID-19 Vaccinations in Children and Adolescents with Cancer and Hematologic DiseasesArticle Published on 2022-06-012022-11-15 Journal: Asian Pacific Journal of Cancer Prevention : APJCP [Category] [DOI] 10.31557/APJCP.2022.23.6.2049 PMC 바로가기
SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients – A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel DiseaseSARS-CoV-2-mRNA 부스터 백신 접종은 면역 저하 환자의 무반응 및 조기 항체 약화를 역전시킵니다 - 고형암, 다발성 골수종 및 염증성 장 질환 환자의 면역 반응을 비교하는 4상 연구Clinical Trial Published on 2022-05-122022-09-12 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.889138 PMC 바로가기 [Article Type] Clinical Trial
Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida플로리다의 암 환자에서 SARS-CoV-2 mRNA-1273 백신 접종에 대한 항체 반응 평가Article Published on 2022-05-012022-09-12 Journal: JAMA Oncology [Category] [DOI] 10.1001/jamaoncol.2022.0001 PMC 바로가기 [Article Type] Article
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study활성 치료 중인 고형 종양 환자에서 BNT162b2 항-SARS-CoV-2 백신 3차 접종 후 면역원성과 안전성: 전향적 코호트 연구Article Published on 2022-04-012022-09-11 Journal: ESMO open [Category] [DOI] 10.1016/j.esmoop.2022.100458 PMC 바로가기 [Article Type] Article
The impact of anti-tumor approaches on the outcomes of cancer patients with COVID-19: a meta-analysis based on 52 cohorts incorporating 9231 participantsResearch Published on 2022-03-042022-10-28 Journal: BMC Cancer [Category] [DOI] 10.1186/s12885-022-09320-x PMC 바로가기 [Article Type] Research
Safety of COVID-19 Vaccine in Patients with Cancer in a High-Volume Comprehensive Cancer CenterBrief Communications Published on 2022-02-112022-10-28 Journal: The oncologist [Category] [DOI] 10.1093/oncolo/oyab037 PMC 바로가기 [Article Type] Brief Communications
Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors TreatmentReview Published on 2022-02-082023-08-30 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.830292 PMC 바로가기 [Article Type] Review
Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients적극적으로 치료받는 암 환자 중 BNT162b2 mRNA COVID-19 백신의 면역원성과 안전성Article Published on 2022-02-072022-09-12 Journal: Journal of the National Cancer Institute [Category] [DOI] 10.1093/jnci/djab174 PMC 바로가기 [Article Type] Article